ACTIVATED CLOTTING FACTORS IN PROTHROMBIN COMPLEX CONCENTRATES

被引：0

作者：

HULTIN, MB ^{[1
]}

机构：

[1] SUNY STONY BROOK,DEPT MED,STONY BROOK,NY 11790

来源：

CIRCULATION | 1978年 / 58卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：207 / 207

页数：1

共 50 条

[41] Reversal of dabigatran using recombinant activated factor vii and activated prothrombin complex concentrates in thromboelastography assay
Chan, H. H. W.
Atkinson, H. M.
Goncharenko, M.
Berry, L. R.
Chan, A. K. C.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 576 - 577
[42] WARFARIN REVERSAL IN ICH: ACTIVATED VERSUS INACTIVATED FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATES
Lenefsky, Mary
Pereira, Deepika
Levasseur-Franklin, Kimberly
Greathouse, Kasey
CRITICAL CARE MEDICINE, 2015, 43 (12)
[43] Comparison of activated factor VII and prothrombin complex concentrates on emergent reversal of coagulopathy.
VanWert, Elizabeth
Hughes, Darrel W.
PHARMACOTHERAPY, 2013, 33 (10): : E202 - E202
[44] Virus safety of prothrombin complex concentrates and factor IX concentrates
Seitz, R
Dodt, J
THROMBOSIS RESEARCH, 1999, 95 (04) : S19 - S23
[45] Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates
Dusel, CH
Grundmann, C
Eich, S
Seitz, R
König, H
BLOOD COAGULATION & FIBRINOLYSIS, 2004, 15 (05) : 405 - 411
[46] Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding
Sheikh-Taha, Marwan
Crawley, R. Monroe
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (03) : 295 - 299
[47] Activated prothrombin complex concentrates and recombinant factor VIIa in the bleeding patient: Are they appropriate and safe?
Aledort, LM
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (06): : 2112 - 2113
[48] FAILURE OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATES IN A HEMOPHILIAC WITH AN ANTI-FACTOR-VIII ANTIBODY
BLATT, PM
WHITE, GC
MCMILLAN, CW
WEBSTER, WP
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (01): : 67 - 67
[49] Non-activated prothrombin complex concentrates for major bleeding in patients on apixaban and rivaroxaban
Marwan Sheikh-Taha
Internal and Emergency Medicine, 2020, 15 : 1123 - 1124
[50] Evidence for the use of activated prothrombin complex concentrates (aPCCs) in the treatment of patients with haemophilia and inhibitors
Wilde, JT
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 : 9 - 12

← 1 2 3 4 5 →